Medicare drug coverage

Atorvastatin in North Dakota: 2027 Part D coverage

26 of 26 Part D plans offered in North Dakota (100%) list atorvastatin on their 2027 formulary, the plan's list of covered drugs (the same share as 2026). 73% of those require prior authorization, step therapy, or a quantity limit. Plan counts include both Medicare Advantage plans with drug coverage (17 MA-PD) and stand-alone drug plans (9 PDP).

License: a US government work, in the public domain (Public Domain Mark 1.0).

For pharmacies and agencies: check a whole drug list against 2027 formularies.

Upload your patient list or your book of clients and Rivvi checks each drug against the CMS 2027 formulary files, plan by plan, so you see tier changes and new limits before the next refill or open enrollment. Free to start. HIPAA BAA included.

Every 2027 plan in North Dakota

Each Part D plan offered in North Dakota, with atorvastatin's 2026 and 2027 tier and its 2027 limits. A tier is the cost level a plan puts a drug on; a lower tier usually costs less. Enter a ZIP to see only the plans offered in that county.

Runs on this page. No account, and the ZIP is not stored.

PA is prior authorization (the plan must approve it first), ST is step therapy (try another drug first), and QL is a quantity limit. D-SNP, C-SNP, and I-SNP are Special Needs Plans: for people with both Medicare and Medicaid, with certain chronic conditions, or who live in a nursing home or need that level of care. Plans are listed by plan ID.

Atorvastatin, 2027 Part D plans, in plan ID order
PlanPlan IDType2026 tier2027 tier2027 PA / ST / QLChange
Aetna Medicare Signature Classic Extra (PPO)H1608-081-000MA-PD (PPO)Tier 1Tier 1QLNo change
Great Plains Medicare Advantage (HMO I-SNP)H1787-001-000MA-PD (HMO I-SNP)Tier 6Tier 6NoneNo change
Great Plain Medicare Advantage Gold (HMO I-SNP)H1787-002-000MA-PD (HMO I-SNP)Tier 6Tier 6NoneNo change
UHC Dual Complete ND-S1 (PPO D-SNP)H2001-085-000MA-PD (PPO D-SNP)Tier 1Tier 1QLAdded QL
AARP Medicare Advantage from UHC FG-0001 (PPO)H2001-118-000MA-PD (PPO)Tier 1Tier 1QLAdded QL
AARP Medicare Advantage from UHC FG-0002 (PPO)H2001-119-000MA-PD (PPO)Tier 1Tier 1QLAdded QL
UHC Complete Care Support FG-5 (PPO C-SNP)H2001-135-000MA-PD (PPO C-SNP)Tier 1Tier 1QLAdded QL
Medica Prime Solution Thrift w/Rx (Cost)H2450-007-000MA-PD (Cost)Tier 1Tier 1QLNo change
Medica Prime Solution Standard w/Rx (Cost)H2450-049-000MA-PD (Cost)Tier 1Tier 1QLNo change
Aetna Medicare Signature Extra (PPO)H5521-759-000MA-PD (PPO)New plan IDTier 1QLNew plan ID in 2027
Align SecureChoice (PPO)H8385-005-000MA-PD (PPO)New plan IDTier 6NoneNew plan ID in 2027
Align SecureChoice Gold (PPO)H8385-006-000MA-PD (PPO)New plan IDTier 6NoneNew plan ID in 2027
Medica Advantage Select (PPO)H8889-012-000MA-PD (PPO)Tier 1Tier 6QLTier 1 to 6
Medica Advantage Preferred (PPO)H8889-013-000MA-PD (PPO)Tier 1Tier 6QLTier 1 to 6
Medica Advantage Value (PPO)H8889-014-000MA-PD (PPO)Tier 1Tier 6QLTier 1 to 6
Medica Advantage Dual (PPO D-SNP)H8889-016-000MA-PD (PPO D-SNP)Tier 1Tier 6QLTier 1 to 6
Aetna Medicare Elite (PPO)H9431-014-000MA-PD (PPO)Tier 1Tier 1QLNo change
Wellcare Classic (PDP)S4802-089-000PDPTier 1Tier 1QLNo change
Wellcare Value Script (PDP)S4802-158-000PDPTier 1Tier 1QLNo change
HealthSpring Assurance Rx (PDP)S5715-043-000PDPNew plan IDTier 1QLNew plan ID in 2027
MedicareBlue Rx Standard (PDP)S5743-001-000PDPTier 1Tier 1QLNo change
Humana Basic Rx Plan (PDP)S5884-145-000PDPTier 2Tier 2NoneNo change
Humana Premier Rx Plan (PDP)S5884-171-000PDPTier 1Tier 1NoneNo change
Humana Value Rx Plan (PDP)S5884-204-000PDPTier 1Tier 1NoneNo change
AARP Medicare Rx Saver from UHC (PDP)S5921-370-000PDPTier 1Tier 1QLAdded QL

Data only, not plan advice. Confirm on Medicare.gov Plan Finder or 1-800-MEDICARE.

North Dakota compared with the nation

73% of the 26 Part D plans offered in North Dakota leave atorvastatin off the 2027 formulary or restrict it, against 68% nationally (5 points higher). North Dakota is tied with 1 other state for rank 15 of 51, at 73% of plans restricting or leaving it off. A plan offered in several states counts in each.

Atorvastatin in every state and by parent organization

2027 compared with 2026

Atorvastatin Part D coverage, 2026 and 2027
Measure20262027Change
Part D plans in the file3326-7
Plans that list it33 (100%)26 (100%)no change
Prior authorization (of plans that list it)0 (0%)0 (0%)no change
Step therapy (of plans that list it)0 (0%)0 (0%)no change
Quantity limit (of plans that list it)18 (55%)19 (73%)+18 points
Any of the three (of plans that list it)18 (55%)19 (73%)+18 points
Not listed or restricted (of all plans)18 (55%)19 (73%)+18 points

Formulary tier

Atorvastatin formulary tier, 2026 and 2027
Tier2026 plans2027 plans
Tier 127 (82%)17 (65%)
Tier 21 (3%)1 (4%)
Tier 65 (15%)8 (31%)

Plan by plan, 2026 to 2027

Atorvastatin: plans in both 2026 and 2027
Plan by planPlans
Same plan ID in both years22
Listed it in 2026, not in 20270 (0%)
Listed it in 2027, not in 20260 (0%)
Moved it to a higher tier4 (18%)
Moved it to a lower tier0 (0%)
Added prior authorization0 (0%)
Added step therapy0 (0%)
Added a quantity limit6 (27%)
Added at least one of the three6 (27%)
Removed at least one of the three0 (0%)
Plan IDs new in 20274
2026 plan IDs not in the 2027 file13

The CMS summary has no count of tier moves down, so "Moved it to a lower tier" is counted from the plan rows on this page: plans with the same plan ID in both years that list atorvastatin both years.

Same plan ID in both years (22) plus 2026 plan IDs not in the 2027 file (13) add up to 35, not the 33 plans offered in North Dakota in 2026, because some plans are offered in different states in 2026 and 2027. 2 plan IDs counted in both years were offered only in other states in 2026.

Atorvastatin in other states

About this data

A plan here is one Part D plan as the CMS formulary files list it: contract, plan, and segment. That covers Medicare Advantage plans with drug coverage and stand-alone drug plans. A plan lists a drug when its formulary has a row for any RxNorm product of that name. When it has several, the row with the lowest tier is the one counted, and restricted means that row has prior authorization, step therapy, or a quantity limit.

A plan with no row for the drug counts as not listing it. That can be a product the file codes another way, so read a low count as a lookup result, not a coverage decision. A state counts every plan the CMS landscape file offers there. Parent organizations are named as CMS names them. The drug list is the top 200 by total Part D spending.

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS CY2026 landscape file, as of September 25, 2025. Publisher page

Source: CMS Medicare Part D Spending by Drug, 2024 data, as of June 25, 2026. Publisher page

Source: US Census Bureau 2020 ZCTA to county relationship file (ZIP lookup), as of December 9, 2021. Publisher page

Try it on your own data today.

Free to start. Most teams are using it the same day.